Nutrition and Body Composition in Acute Lymphoblastic Leukemia

Service: Trial Number:
Principal Investigator: Conducted at:
Miller Children`s & Women`s Hospital Long Beach
Currently enrolling additional patients:

Acute Lymphoblastic Leukemia (ALL) treatment often results in bone weakness due, in part, to Vitamin D insufficiency. The resultant large number of survivors from ALL have a significant possibility of suffering from poor bone health. It is felt that Vitamin D intervention during and after treatment can prevent this outcome. This is a randomized trial of vitamin D and calcium supplementation in vitamin D-insufficient subjects. Eligible patients will be identified at the Jonathan Jaques Children’s Cancer Center (JJCCC) and the MCH/PAHO outpatient clinic. There are two groups in this study: Group A: Newly diagnosed ALL patients and Group B: Off-therapy ALL patients. The intervention arm consists of vitamin D supplements administered once every two months in either the inpatient or outpatient settings, plus daily chewable calcium carbonate (Tums©) taken at home. For every two patients receiving the Vitamin D and calcium intervention, one patient will be followed as per standard of care (a “2:1 randomization”).

MemorialCare Research Center Contact Form

For further information about this study or to express your interest in this study, please fill out and submit this form.
The email to associate with this registration.